{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:46:53Z","timestamp":1790398013315,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jhin.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T20:17:10Z","timestamp":1404418630000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Managing the risk of iatrogenic transmission of Creutzfeldt\u2013Jakob disease in the UK"],"prefix":"10.1016","volume":"88","author":[{"given":"V.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nacul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.N.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2014.06.002_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/385197a0","article-title":"Predicting the CJD epidemic in humans","volume":"385","author":"Cousens","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jhin.2014.06.002_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35020688","article-title":"Predicted vCJD mortality in Great Britain","volume":"406","author":"Ghani","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jhin.2014.06.002_bib3","series-title":"Nineteenth annual report 2012: Creutzfeldt\u2013Jakob disease surveillance in the UK","author":"National CJD","year":"2012"},{"key":"10.1016\/j.jhin.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1098\/rsif.2004.0017","article-title":"Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility","volume":"2","author":"Clarke","year":"2005","journal-title":"J\u00a0R Soc Interface"},{"key":"10.1016\/j.jhin.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-0463.2002.100110.x","article-title":"Pathological diagnosis of variant Creutzfeldt\u2013Jakob disease","volume":"110","author":"Ironside","year":"2002","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.jhin.2014.06.002_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jhin.2014.06.002_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/01.WNL.0000084000.27403.15","article-title":"Creutzfeldt\u2013Jakob disease in United Kingdom patients treated with human pituitary growth hormone","volume":"61","author":"Swerdlow","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jhin.2014.06.002_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/jnnp.2005.073395","article-title":"Dura mater-associated Creutzfeldt\u2013Jakob disease: experience from surveillance in the UK","volume":"77","author":"Heath","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jhin.2014.06.002_bib9","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion","volume":"83","author":"Hunter","year":"2002","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhin.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2014.06.002_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt\u2013Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.jhin.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jhin.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2014.06.002_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.321.7252.17","article-title":"Risk of acquiring Creutzfeldt\u2013Jakob disease from blood transfusions: systematic review of case\u2013control studies","volume":"321","author":"Wilson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jhin.2014.06.002_bib15","series-title":"Transmissible spongiform encephalopathy agents: safe working and the prevention of infection","author":"Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Management Subgroup (ACDP TSE RMS)","year":"1998"},{"key":"10.1016\/j.jhin.2014.06.002_bib16","series-title":"Health Service Circular 2000\/032: decontamination of medical devices","author":"Department of Health","year":"2000"},{"key":"10.1016\/j.jhin.2014.06.002_bib17","series-title":"Patient safety and reduction of risk of transmission of Creutzfeldt\u2013Jakob disease (CJD) via interventional procedures","author":"National Institute for Health and Clinical Excellence","year":"2006"},{"key":"10.1016\/j.jhin.2014.06.002_bib18","series-title":"CJD Incidents Panel Framework Document: Management of possible exposure to CJD through medical procedures","author":"CJD Incidents Panel","year":"2005"},{"key":"10.1016\/j.jhin.2014.06.002_bib19","series-title":"Assessing the implications for blood donors if recipients are infected with vCJD","author":"Department of Health","year":"2005"},{"key":"10.1016\/j.jhin.2014.06.002_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1258\/147775006778246478","article-title":"vCJD donor notification exercise: 2005","volume":"1","author":"Hewitt","year":"2006","journal-title":"Clin Ethics"},{"key":"10.1016\/j.jhin.2014.06.002_bib21","unstructured":"Department of Health. Other recipients of blood from donors to vCJD cases: implications of risk assessment and options for action. Paper for CJD Incidents Panel, 7 September 2005."},{"key":"10.1016\/j.jhin.2014.06.002_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1057\/ori.2006.15","article-title":"The implications for blood donors if a recipient develops vCJD","volume":"19","author":"Bennett","year":"2006","journal-title":"OR Insight"},{"key":"10.1016\/j.jhin.2014.06.002_bib23","series-title":"Risk assessment of exposure to vCJD infectivity in blood and blood products","author":"Det Norske Veritas Consulting","year":"2003"},{"key":"10.1016\/j.jhin.2014.06.002_bib24","series-title":"Fourth annual report, 1st September 2003 to 31st August 2004","author":"CJD Incidents Panel","year":"2004"},{"key":"10.1016\/j.jhin.2014.06.002_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2516.2010.02220.x","article-title":"Risk reduction strategies for variant Creutzfeldt\u2013Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders","volume":"16","author":"Millar","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jhin.2014.06.002_bib26","series-title":"Risk assessment for transmission of vCJD via surgical instruments: a modelling approach and numerical scenarios","author":"Department of Health","year":"2001"},{"key":"10.1016\/j.jhin.2014.06.002_bib27","series-title":"Assessing the risk of vCJD transmission via surgery: an interim review","author":"Department of Health","year":"2005"},{"key":"10.1016\/j.jhin.2014.06.002_bib28","series-title":"Notification of potential exposure to variant Creutzfeldt\u2013Jakob disease through plasma products: report to the CJD Incidents Panel by the HPA","author":"Health Protection Agency","year":"2004"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670114001820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670114001820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T18:56:04Z","timestamp":1538420164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670114001820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0195670114001820"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2014.06.002","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing the risk of iatrogenic transmission of Creutzfeldt\u2013Jakob disease in the UK","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2014.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}